Glutathione vs NAD+ Precursors (NMN/NR)
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, Glutathione or NAD+ Precursors (NMN/NR)?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between Glutathione and NAD+ Precursors (NMN/NR)?
Glutathione is the primary intracellular antioxidant (direct ROS scavenging); NAD+ is a coenzyme for sirtuin-mediated metabolic regulation and DNA repair - antioxidant defense vs. metabolic signaling, with no mechanistic overlap.
Evidence Comparison
Glutathione: extensive biochemistry, small human studies on IV and liposomal forms, mixed oral bioavailability data. NAD+: precursor supplementation (NMN, NR) has human pharmacokinetic data (Yoshino 2021, Martens 2018) showing NAD+ elevation, but clinical outcome trials are limited. Both have Level C evidence for longevity claims; NAD+ precursor research is more active.
Evidence Context Favoring Glutathione
Oxidative stress, detoxification, or direct antioxidant research contexts.
Evidence Context Favoring NAD+ Precursors (NMN/NR)
Sirtuin biology, metabolic aging, or DNA repair pathway research; NAD+ precursor studies are generating more active clinical data.
Side-by-Side Snapshot
| Evidence grade | Glutathione: Level C NAD+ Precursors (NMN/NR): Level B |
|---|---|
| Research status | Glutathione: Phase 2 NAD+ Precursors (NMN/NR): Phase 2 |
| Primary category | Glutathione: Anti-Aging & Longevity NAD+ Precursors (NMN/NR): Anti-Aging & Longevity |
| Cited studies | Glutathione: 3 NAD+ Precursors (NMN/NR): 3 |